Patents Assigned to EVOLVE BIOSYSTEMS INC
  • Patent number: 11318175
    Abstract: The inventions described herein relate generally to the use of compositions to increase output of acetate and lactate while reducing pH and the levels of pathogenic bacteria and inflammation in the gut of a nursing infant mammal including humans. These compositions generally comprise one or more bacterial strains selected for their growth on mammalian milk oligosaccharides, a source of mammalian milk oligosaccharides, and, optionally, nutritive components required for the growth of that infant mammal.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: May 3, 2022
    Assignee: EVOLVE BIOSYSTEMS, INC.
    Inventors: David Kyle, Steven Frese, Samara Freeman-Sharkey, Bethany Henrick
  • Patent number: 10716816
    Abstract: Some embodiments of the invention include a composition and method for treating dysbiosis in infants. The composition may include a mixture of activated bifidobacteria and a complex oligosaccharide wherein the complex oligosaccharide may be derived from a human or non-human source.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: July 21, 2020
    Assignee: EVOLVE BIOSYSTEMS INC.
    Inventors: David Kyle, David Mills, Samara Freeman-Sharkey
  • Publication number: 20170304375
    Abstract: Some embodiments of the invention include a composition and method for treating dysbiosis in infants. The composition may include a mixture of activated bifidobacteria and a complex oligosaccharide wherein the complex oligosaccharide may be derived from a human or non-human source.
    Type: Application
    Filed: October 23, 2015
    Publication date: October 26, 2017
    Applicant: EVOLVE BIOSYSTEMS INC
    Inventors: David KYLE, David MILLS, Samara FREEMAN-SHARKY